117 related articles for article (PubMed ID: 18135264)
1. [Irgapyrin as an anti-rheumatic].
BELART W
Schweiz Med Wochenschr; 1949 Jun; 79(25):582-4. PubMed ID: 18135264
[No Abstract] [Full Text] [Related]
2. [Irgapyrin therapy of rheumatism].
PORYALI E
Ther Umsch; 1952 Apr; 9(1):11-2. PubMed ID: 12984355
[No Abstract] [Full Text] [Related]
3. [Application of irgapyrin in the treatment of rheumatism].
LACROIX A; BONNET J; JOUANNEAU H; SAYAG A
Alger Medicale; 1953 Jan; 57(1):64-9. PubMed ID: 13040254
[No Abstract] [Full Text] [Related]
4. [Treatment of rheumatism with parenteral pyramidon-pyrazolidine (irgapyrin)].
ROMERO E
Rev Clin Esp; 1951 Jul; 42(2):91-100. PubMed ID: 14892391
[No Abstract] [Full Text] [Related]
5. [Butazolidine as antirheumatic and its comparison with irgapyrin].
BELART W
Dtsch Med Wochenschr; 1953 Jan; 78(4):129-31. PubMed ID: 13043409
[No Abstract] [Full Text] [Related]
6. [Investigations on the effect of irgapyrin on the secretion of eosinophils and corticosterones].
RECHENBERG HK
Helv Med Acta; 1951 Oct; 18(4-5):429-35. PubMed ID: 14873175
[No Abstract] [Full Text] [Related]
7. [G 15903, irgapyrin, as an analgesic and antiphlogistic].
TROMPIZ G
Ther Umsch Med Bibliogr; 1950 Oct; 7(7):112-4. PubMed ID: 14787969
[No Abstract] [Full Text] [Related]
8. [Irgapyrin (Geigy), a new pyrazolic antirheumatic and analgesic].
LOEWENHARDT F
Dtsch Med Wochenschr; 1950 Apr; 75(14):459-60. PubMed ID: 15411837
[No Abstract] [Full Text] [Related]
9. [Therapy of acute rheumatic diseases in childhood with irgapyrin].
FALK W
Med Klin; 1952 Sep; 47(36):1190-4. PubMed ID: 13001853
[No Abstract] [Full Text] [Related]
10. [Wofapyrin and butalidon in the treatment of rheumatic diseases].
SEIDEL K
Dtsch Gesundheitsw; 1955 May; 10(21):741-4. PubMed ID: 13241088
[No Abstract] [Full Text] [Related]
11. [Treatment of rheumatism in childhood with irgapyrin].
REY SUMAY RS; FRASCHINA HL
Dia Med; 1957 Apr; 29(24):678-80. PubMed ID: 13447671
[No Abstract] [Full Text] [Related]
12. [Aminophenazone or wofapyrine? A contribution to the therapy of rheumatic diseases in general practice].
KNOBLAUCH H
Dtsch Gesundheitsw; 1961 Nov; 16():2073-8. PubMed ID: 14457271
[No Abstract] [Full Text] [Related]
13. [The effect of irgapyrin on fluid balance and carbohydrate metabolism (irgapyrin edema and irgapyrin glycosuria)].
VON RECHENBERG HK
Klin Wochenschr; 1951 Nov; 29(43-44):726-30. PubMed ID: 14939614
[No Abstract] [Full Text] [Related]
14. [Irgapyrin as anti-inflammatory drug in the treatment of infectious diseases].
CRISCUOLO E; PASSADORE JB; LEVIN D; LARREYNA P
Prensa Med Argent; 1955 Nov; 42(45):3431-5. PubMed ID: 13310475
[No Abstract] [Full Text] [Related]
15. [Treatment of rheumatic diseases with Sigma-Elmedal under spa-conditions].
Engel P
Fortschr Med; 1974 Feb; 92(6):254-6. PubMed ID: 4544747
[No Abstract] [Full Text] [Related]
16. Phenylbutazone (butazolidin) and butapyrin; a study of clinical effects in arthritis and gout.
KUZELL WC; SCHAFFARZICK RW
Calif Med; 1952 Nov; 77(5):319-25. PubMed ID: 13009482
[TBL] [Abstract][Full Text] [Related]
17. [The dangers of phenylbutazone and irgapyrin].
MEYLER L
Geneeskd Gids; 1955 Nov; 33(23):468-71. PubMed ID: 13285696
[No Abstract] [Full Text] [Related]
18. [Testing of antirheumatic agents such as prednisolone, phenylbutazone, pyramidon and aspirin on depolarization thrombosis in cats].
ALEXANDER K; KELLER H
Arch Int Pharmacodyn Ther; 1962 Jan; 135():118-26. PubMed ID: 13860340
[No Abstract] [Full Text] [Related]
19. [Review of 4 years of irgapyrin and butazolidine therapy of internal diseases].
BARCZYK W; ROTH G
Med Klin; 1956 Jun; 51(26):1112-4. PubMed ID: 13348004
[No Abstract] [Full Text] [Related]
20. [About the pharmacological properties of irgapyrin, a new preparation from the pyrazole series].
WILHELMI G
Schweiz Med Wochenschr; 1949 Jun; 79(25):577-82. PubMed ID: 18135263
[No Abstract] [Full Text] [Related]
[Next] [New Search]
